Histone Deacetylase 7 and FoxA1 in Estrogen-Mediated Repression of RPRM
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Activation of estrogen receptor alpha (ERalpha) results in both induction and repression of gene transcription; while mechanistic details of estrogen induction are well described, details of repression remain largely unknown. We characterized several ERalpha-repressed targets and examined in detail the mechanism for estrogen repression of Reprimo (RPRM), a cell cycle inhibitor. Estrogen repression of RPRM is rapid and robust and requires a tripartite interaction between ERalpha, histone deacetylase 7 (HDAC7), and FoxA1. HDAC7 is the critical HDAC needed for repression of RPRM; it can bind to ERalpha and represses ERalpha's transcriptional activity--this repression does not require HDAC7's deacetylase activity. We further show that the chromatin pioneer factor FoxA1, well known for its role in estrogen induction of genes, is recruited to the RPRM promoter, is necessary for repression of RPRM, and interacts with HDAC7. Like other FoxA1 recruitment sites, the RPRM promoter is characterized by H3K4me1/me2. Estrogen treatment causes decreases in H3K4me1/me2 and release of RNA polymerase II (Pol II) from the RPRM proximal promoter. Overall, these data implicate a novel role for HDAC7 and FoxA1 in estrogen repression of RPRM, a mechanism which could potentially be generalized to many more estrogen-repressed genes and hence be important in both normal physiology and pathological processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Métivier, R., Penot, G., Hübner, M. R., Reid, G., Brand, H., Koš, M., & Gannon, F. (2003) · Cell · doi:10.1016/s0092-8674(03)00934-6 · Cited by 1,431
FoxA1 Translates Epigenetic Signatures into Enhancer-Driven Lineage-Specific Transcription
Lupien, M., Eeckhoute, J., Meyer, C. A., Wang, Q., Zhang, Y., Li, W., Carroll, J. S., Liu, X. S., & Brown, M. (2008) · Cell · doi:10.1016/j.cell.2008.01.018 · Cited by 983 · cited 8×
“In addition, FoxA1 has been reported to play a role in regulating basal expression of E2-repressed genes and a significant fraction of its binding sites have a relatively closed chromatin conformation and are characterized by repressive histone marks (3, 47).”
BackgroundMethodInfluentialFischle, W., Dequiedt, F., Hendzel, M. J., Guenther, M. G., Lazar, M. A., Voelter, W., & Verdin, E. (2002) · Molecular Cell · doi:10.1016/s1097-2765(01)00429-4 · Cited by 754 · cited 10×
“However, out of the 10 tested HDACs, only HDAC7 affected E2 repression of RPRM—knockdown of HDAC7 resulted in complete relief of repression (Fig.”
BackgroundInfluentialSelf-citationExtranuclear Steroid Receptors: Nature and Actions
Hammes, S. R., & Levin, E. R. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0022 · Cited by 475
Human HDAC7 Histone Deacetylase Activity Is Associated with HDAC3in Vivo
Fischle, W., Dequiedt, F., Fillion, M., Hendzel, M. J., Voelter, W., & Verdin, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104935200 · Cited by 232
Self-citationHistone Deacetylase 3 Interacts with and Deacetylates Myocyte Enhancer Factor 2
Grégoire, S., Xiao, L., Nie, J., Zhang, X., Xu, M., Li, J., Wong, J., Seto, E., & Yang, X.-J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00882-06 · Cited by 203
Research works printed but not linked: 66
- An J., 1999, Proc. Natl. Acad. Sci. U. S. A, 96, 15161, 10.1073/pnas.96.26.15161 · DOI · Paper page
- Badve S., 2007, Clin. Cancer Res, 13, 4415, 10.1158/1078-0432.CCR-07-0122 · DOI · Paper page
- Bretschneider N., 2008, Cancer Res, 68, 106, 10.1158/0008-5472.CAN-07-5647 · DOI
- Carroll J. S., 2005, Cell, 122, 33, 10.1016/j.cell.2005.05.008 · DOI · Paper page
- Carroll J. S., 2006, Nat. Genet, 38, 1289, 10.1038/ng1901 · DOI · Paper page
- Cicatiello L., 2004, J. Mol. Endocrinol, 32, 719, 10.1677/jme.0.0320719 · DOI · Paper page
- Creighton C. J., 2006, Genome Biol, 7, R28, 10.1186/gb-2006-7-4-r28 · DOI
- Cunliffe H. E., 2003, Cancer Res, 63, 7158
- Downes M., 2000, Proc. Natl. Acad. Sci. U. S. A, 97, 10330, 10.1073/pnas.97.19.10330 · DOI · Paper page
- Dressel U., 2001, J. Biol. Chem, 276, 17007, 10.1074/jbc.M101508200 · DOI · Paper page
- Eeckhoute J., 2006, Genes Dev, 20, 2513, 10.1101/gad.1446006 · DOI · Paper page
- Fernandes I., 2003, Mol. Cell, 11, 139, 10.1016/S1097-2765(03)00014-5 · DOI · Paper page
- Frasor J., 2003, Endocrinology, 144, 4562, 10.1210/en.2003-0567 · DOI · Paper page
- Frasor J., 2004, Cancer Res, 64, 1522, 10.1158/0008-5472.CAN-03-3326 · DOI · Paper page
- Gao C., 2008, Mol. Cell. Biol, 28, 5658, 10.1128/MCB.00874-08 · DOI
- Garcia-Arencibia M., 2005, Leuk. Res, 29, 79, 10.1016/j.leukres.2004.05.012 · DOI
- Garcia-Bassets I., 2007, Cell, 128, 505, 10.1016/j.cell.2006.12.038 · DOI · Paper page
- Gottardis M. M., 1995, Endocrinology, 136, 5659, 10.1210/endo.136.12.7588321 · doi:10.1210/endo.136.12.7588321
- Gregoire S., 2005, Mol. Cell. Biol, 25, 2273, 10.1128/MCB.25.6.2273-2287.2005 · DOI · Paper page
- Higgins K. J., 2008, Mol. Endocrinol, 22, 388, 10.1210/me.2007-0319 · DOI
- Huang E. Y., 2000, Genes Dev, 14, 45, 10.1101/gad.14.1.45 · DOI · Paper page
- Huang M. C., 2002, DNA Cell Biol, 21, 561, 10.1089/104454902320308933 · DOI
- Hurtado A., 2008, Nature, 456, 663, 10.1038/nature07483 · DOI · Paper page
- Jensen E. D., 2008, J. Bone Miner. Res, 23, 361, 10.1359/jbmr.071104 · DOI · Paper page
- Jiang S., 2006, Mol. Endocrinol, 20, 311, 10.1210/me.2005-0100 · DOI
- Kaipparettu B. A., 2008, Int. J. Cancer, 123, 66, 10.1002/ijc.23480 · DOI
- Kalaitzidis D., 2005, Trends Endocrinol. Metab, 16, 46, 10.1016/j.tem.2005.01.004 · DOI · Paper page
- Karvonen U., 2006, Exp. Cell Res, 312, 3165, 10.1016/j.yexcr.2006.06.018 · DOI
- Kawai H., 2003, Int. J. Cancer, 107, 353, 10.1002/ijc.11403 · DOI · Paper page
- Kelley K. M., 2003, Cancer Res, 63, 2820
- Kim J., 2003, Nucleic Acids Res, 31, 6741, 10.1093/nar/gkg909 · DOI
- Klinge C. M., 2001, Nucleic Acids Res, 29, 2905, 10.1093/nar/29.14.2905 · DOI · Paper page
- Kurebayashi J., 2000, Clin. Cancer Res, 6, 512
- Kurtev V., 2004, J. Biol. Chem, 279, 24834, 10.1074/jbc.M312300200 · DOI
- Kushner P. J., 2000, J. Steroid Biochem. Mol. Biol, 74, 311, 10.1016/S0960-0760(00)00108-4 · DOI · Paper page
- Laganiere J., 2005, Proc. Natl. Acad. Sci. U. S. A, 102, 11651, 10.1073/pnas.0505575102 · DOI · Paper page
- Leong H., 2005, Mol. Endocrinol, 19, 2930, 10.1210/me.2005-0178 · DOI
- Lin C. Y., 2004, Genome Biol, 5, R66, 10.1186/gb-2004-5-9-r66 · DOI · Paper page
- Lin C. Y., 2007, PLoS Genet, 3, e87, 10.1371/journal.pgen.0030087 · DOI · Paper page
- Liu W., 2006, J. Biol. Chem, 281, 9837, 10.1074/jbc.C600001200 · DOI · Paper page
- Lyst M. J., 2007, Biochem. Soc. Trans, 35, 1389, 10.1042/BST0351389 · DOI
- Madak-Erdogan Z., 2008, Mol. Endocrinol, 22, 2116, 10.1210/me.2008-0059 · DOI · Paper page
- Metzger E., 2005, Nature, 437, 436, 10.1038/nature04020 · DOI · Paper page
- Newman S. P., 2000, Oncogene, 19, 490, 10.1038/sj.onc.1203416 · DOI
- Nishidate T., 2004, Int. J. Oncol, 25, 797
- Oesterreich S., 2003, Cancer Res, 63, 5203
- Ohki R., 2000, J. Biol. Chem, 275, 22627, 10.1074/jbc.C000235200 · DOI · Paper page
- Parra M., 2007, Genes Dev, 21, 638, 10.1101/gad.1513107 · DOI · Paper page
- Patrone G., 2000, Biotechniques, 29, 1012, 10.2144/00295st02 · DOI
- Perissi V., 2000, Oncogene, 19, 280, 10.1038/sj.onc.1203303 · doi:10.1038/sj.onc.1203303
- Ray P., 1997, FEBS Lett, 409, 79, 10.1016/S0014-5793(97)00487-0 · DOI · Paper page
- Safe S., 2001, Vitam. Horm, 62, 231, 10.1016/S0083-6729(01)62006-5 · DOI · Paper page
- Schuetz A., 2008, J. Biol. Chem, 283, 11355, 10.1074/jbc.M707362200 · DOI · Paper page
- Sentis S., 2005, Mol. Endocrinol, 19, 2671, 10.1210/me.2005-0042 · DOI · Paper page
- Shang Y., 2000, Cell, 103, 843, 10.1016/S0092-8674(00)00188-4 · DOI · Paper page
- Shang Y., 2002, Mol. Cell, 9, 601, 10.1016/S1097-2765(02)00471-9 · DOI · Paper page
- Stoner M., 2000, J. Biol. Chem, 275, 22769, 10.1074/jbc.M002188200 · DOI
- Stossi F., 2006, J. Biol. Chem, 281, 16272, 10.1074/jbc.M513405200 · DOI · Paper page
- Stossi F., 2009, Mol. Cell. Biol, 29, 1749, 10.1128/MCB.01476-08 · DOI
- Takahashi T., 2005, Int. J. Cancer, 115, 503, 10.1002/ijc.20910 · doi:10.1002/ijc.20910
- Townson S. M., 2003, J. Biol. Chem, 278, 20059, 10.1074/jbc.M212988200 · DOI · Paper page
- Uray I. P., 2004, Cancer Lett, 207, 101, 10.1016/j.canlet.2003.10.021 · DOI
- Vu E. H., 2007, Biochemistry, 46, 9795, 10.1021/bi700316g · DOI
- Watanabe H., 2002, Genes Cells, 7, 497, 10.1046/j.1365-2443.2002.00535.x · DOI
- Wei L. N., 2001, J. Biol. Chem, 276, 16107, 10.1074/jbc.M010185200 · DOI
- Zhu P., 2006, Cell, 124, 615, 10.1016/j.cell.2005.12.032 · DOI · Paper page
Cited by
Pioneer transcription factors: establishing competence for gene expression
Zaret, K. S., & Carroll, J. S. (2011) · Genes & Development · doi:10.1101/gad.176826.111 · Cited by 1,589
New and emerging HDAC inhibitors for cancer treatment
West, A. C., & Johnstone, R. W. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69738 · Cited by 1,404
Histone deacetylases and cancer
Barneda-Zahonero, B., & Parra, M. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.07.003 · Cited by 446
Estrogen as a key regulator of energy homeostasis and metabolic health
Mahboobifard, F., Pourgholami, M. H., Jorjani, M., Dargahi, L., Amiri, M., Sadeghi, S., & Tehrani, F. R. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113808 · Cited by 154
Caslini, C., Hong, S., Ban, Y. J., Chen, X. S., & Ince, T. A. (2019) · Oncogene · doi:10.1038/s41388-019-0897-0 · Cited by 121
Metadata
- Authors
- Malik, S., Jiang, S., Garee, J. P., Verdin, E., Lee, A. V., O'Malley, B. W., Zhang, M., Belaguli, N. S., & Oesterreich, S.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2010-01-01
- Volume
- 30
- Issue
- 2
- Pages
- 399-412
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2012794169
- Cited by
- 79
- References
- 7
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.